Corcept Therapeutics Inc
CORT· Nasdaq
Released Mar 6, 2017, after the close
10-K filed Mar 6, 2017, 65 days after period end · 0001564590-17-003493
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2016 | Q4 2015 | Q4 2014 | Q4 2013 |
|---|---|---|---|---|
| Revenue | $23.81M | $14.97M | $9.01M | $4.12M |
| Net Income | $4.60M | $959.00K | -$3.90M | -$11.12M |
| EPS Diluted | $0.04 |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.01 |
| -$0.04 |
| -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.